✦ LIBER ✦

PMH41 COST UTILITY OF EEG BIOMARKERS FOR PERSONALIZED TREATMENT OF MAJOR DEPRESSION

✍ Scribed by KN Simpson; Z Nahas; AF Leuchter; A Siegel; S Greenwald

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH41 COST-UTILITY ANALYSIS OF ESCITALOP

✍ Leshno, M; Ben-Amnon, Y; Brignone, M; Marteau, F; Hansen, K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PMH21 COST-UTILITY ANALYSIS OF ANTIDEPRE

✍ DC Malone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMH41 Antidepressant Treatment Patterns,

✍ K. Isenberg; D. Eisenberg; R. Sanchez; J. Alvir; J. Wang; T. Gu; J. White 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH39 THE COST-UTILITY OF AGOMELATINE IN

✍ Golicki, D; Pajaąk, K; Dbrowska, A; Niewada, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PMH35 Cost-Effectiveness of Agomelatine

✍ M. Tatar; N. Dilbaz; E.T. Oral; M. Tan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

EEG biomarkers in major depressive disor

✍ Olbrich, Sebastian; Arns, Martijn 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 206 KB